SABCS 2022: Interrupting Endocrine Therapy to Pursue Pregnancy Not Associated With Increased Recurrence Rates in Early-Stage Breast Cancer
Recurrence rates were similar to those in external control clinical trials; pregnancy and childbirth rates were on par with or better than those of the general public
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.